{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:17:52Z","timestamp":1790745472863,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>T cells are the immunological cornerstone in host defense against infections by intracellular bacterial pathogens, such as virulent Francisella tularensis spp. tularensis (Ftt). The general paucity of novel vaccines for Ftt during the past 60 y can, in part, be attributed to the poor understanding of immune parameters required to survive infection. Thus, we developed a strategy utilizing classical immunological tools to elucidate requirements for effective adaptive immune responses directed against Ftt. Following generation of various Francisella strains expressing well-characterized lymphocytic choriomeningitis virus epitopes, we found that survival correlated with persistence of Ag-specific CD4+ T cells. Function of these cells was confirmed in their ability to more effectively control Ftt replication in vitro. The importance of understanding the Ag-specific response was underscored by our observation that inclusion of an epitope that elicits high-avidity CD4+ T cells converted a poorly protective vaccine to one that engenders 100% protection. Taken together, these data suggest that improved efficacy of current tularemia vaccine platforms will require targeting appropriate Ag-specific CD4+ T cell responses and that elucidation of Francisella epitopes that elicit high-avidity CD4+ T cell responses, specifically in humans, will be required for successful vaccine development.<\/jats:p>","DOI":"10.4049\/jimmunol.1600879","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T02:59:14Z","timestamp":1471661954000},"page":"2738-2747","source":"Crossref","is-referenced-by-count":19,"title":["Inclusion of Epitopes That Expand High-Avidity CD4+ T Cells Transforms Subprotective Vaccines to Efficacious Immunogens against Virulent <i>Francisella tularensis<\/i>"],"prefix":"10.1093","volume":"197","author":[{"given":"Lydia M","family":"Roberts","sequence":"first","affiliation":[{"name":"Immunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Hamilton, MT 59840"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah D","family":"Crane","sequence":"additional","affiliation":[{"name":"Immunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Hamilton, MT 59840"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara D","family":"Wehrly","sequence":"additional","affiliation":[{"name":"Immunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Hamilton, MT 59840"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua R","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Carver College of Medicine, University of Iowa , Iowa City, IA 52242"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley D","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Carver College of Medicine, University of Iowa , Iowa City, IA 52242"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharine M","family":"Bosio","sequence":"additional","affiliation":[{"name":"Immunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Hamilton, MT 59840"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,10,1]]},"reference":[{"key":"2025030617525889800_r1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/MMBR.00028-09","article-title":"Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development","volume":"73","author":"Pechous","year":"2009","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"2025030617525889800_r2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.1997.03550050074036","article-title":"Biological warfare. A historical perspective","volume":"278","author":"Christopher","year":"1997","journal-title":"JAMA"},{"key":"2025030617525889800_r3","volume-title":"Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World, Told from the Inside by the Man Who Ran It.","author":"Alibek","year":"1999"},{"key":"2025030617525889800_r4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4049\/jimmunol.87.4.415","article-title":"Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig","volume":"87","author":"Eigelsbach","year":"1961","journal-title":"J. Immunol."},{"key":"2025030617525889800_r5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/br.25.3.262-267.1961","article-title":"Aerosol infection of man with Pasteurella tularensis","volume":"25","author":"McCrumb","year":"1961","journal-title":"Bacteriol. Rev."},{"key":"2025030617525889800_r6","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.vaccine.2013.05.096","article-title":"Live attenuated tularemia vaccines: recent developments and future goals","volume":"31","author":"Marohn","year":"2013","journal-title":"Vaccine"},{"key":"2025030617525889800_r7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2217\/fmb.11.22","article-title":"Tularemia vaccines: recent developments and remaining hurdles","volume":"6","author":"Conlan","year":"2011","journal-title":"Future Microbiol."},{"key":"2025030617525889800_r8","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1016\/S0264-410X(03)00386-4","article-title":"Tularemia in BALB\/c and C57BL\/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background","volume":"21","author":"Chen","year":"2003","journal-title":"Vaccine"},{"key":"2025030617525889800_r9","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.vaccine.2004.10.034","article-title":"Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an \u03b1\u03b2 T cell- and interferon \u03b3-dependent mechanism","volume":"23","author":"Wayne Conlan","year":"2005","journal-title":"Vaccine"},{"key":"2025030617525889800_r10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/CVI.00648-14","article-title":"Successful protection against tularemia in C57BL\/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells","volume":"22","author":"Griffin","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"2025030617525889800_r11","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.4049\/jimmunol.178.7.4538","article-title":"Active suppression of the pulmonary immune response by Francisella tularensis Schu4","volume":"178","author":"Bosio","year":"2007","journal-title":"J. Immunol."},{"key":"2025030617525889800_r12","doi-asserted-by":"crossref","first-page":"e33349","DOI":"10.1371\/journal.pone.0033349","article-title":"Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia","volume":"7","author":"Crane","year":"2012","journal-title":"PLoS One"},{"key":"2025030617525889800_r13","doi-asserted-by":"crossref","first-page":"e1005065","DOI":"10.1371\/journal.ppat.1005065","article-title":"IL-27 signaling is crucial for survival of mice infected with African trypanosomes via preventing lethal effects of CD4+ T cells and IFN-\u03b3","volume":"11","author":"Liu","year":"2015","journal-title":"PLoS Pathog."},{"key":"2025030617525889800_r14"},{"key":"2025030617525889800_r15","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1016\/j.vaccine.2010.07.072","article-title":"Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs","volume":"28","author":"Anderson","year":"2010","journal-title":"Vaccine"},{"key":"2025030617525889800_r16","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1128\/CVI.00319-13","article-title":"Lipids derived from virulent Francisella tularensis broadly inhibit pulmonary inflammation via Toll-like receptor 2 and peroxisome proliferator-activated receptor \u03b1","volume":"20","author":"Crane","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"2025030617525889800_r17","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.molimm.2009.01.008","article-title":"Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS","volume":"46","author":"Valentino","year":"2009","journal-title":"Mol. Immunol."},{"key":"2025030617525889800_r18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2567.2010.03387.x","article-title":"Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets","volume":"132","author":"Valentino","year":"2011","journal-title":"Immunology"},{"key":"2025030617525889800_r19","doi-asserted-by":"crossref","first-page":"e20050","DOI":"10.1371\/journal.pone.0020050","article-title":"Whole-genome immunoinformatic analysis of F. tularensis: predicted CTL epitopes clustered in hotspots are prone to elicit a T-cell response","volume":"6","author":"Zvi","year":"2011","journal-title":"PLoS One"},{"key":"2025030617525889800_r20","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1128\/iai.65.6.2183-2189.1997","article-title":"Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein","volume":"65","author":"Golovliov","year":"1997","journal-title":"Infect. Immun."},{"key":"2025030617525889800_r21","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat. Med."},{"key":"2025030617525889800_r22","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"key":"2025030617525889800_r23","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/eji.201041141","article-title":"Increased apoptosis, curtailed expansion and incomplete differentiation of CD8+ T cells combine to decrease clearance of L. monocytogenes in old mice","volume":"41","author":"Smithey","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"2025030617525889800_r24","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/eji.200737504","article-title":"Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations","volume":"37","author":"Beveridge","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"2025030617525889800_r25","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1016\/j.vaccine.2014.05.013","article-title":"IFN-\u03b3, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis live vaccine stain infection","volume":"32","author":"Roberts","year":"2014","journal-title":"Vaccine"},{"key":"2025030617525889800_r26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/iai.60.1.84-89.1992","article-title":"In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies","volume":"60","author":"Leiby","year":"1992","journal-title":"Infect. Immun."},{"key":"2025030617525889800_r27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.micinf.2005.09.014","article-title":"Myeloid differentiation factor-88 (MyD88) is essential for control of primary in vivo Francisella tularensis LVS infection, but not for control of intra-macrophage bacterial replication","volume":"8","author":"Collazo","year":"2006","journal-title":"Microbes Infect."},{"key":"2025030617525889800_r28","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1099\/13500872-142-6-1369","article-title":"The requirement of tumour necrosis factor-\u03b1 and interferon-\u03b3 for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum","volume":"142","author":"Sj\u00f6stedt","year":"1996","journal-title":"Microbiology"},{"key":"2025030617525889800_r29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0882-4010(89)90022-3","article-title":"The requirement for gamma interferon in resistance of mice to experimental tularemia","volume":"7","author":"Anthony","year":"1989","journal-title":"Microb. Pathog."},{"key":"2025030617525889800_r30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.0105-2896.2010.00897.x","article-title":"Heterologous immunity between viruses","volume":"235","author":"Welsh","year":"2010","journal-title":"Immunol. Rev."},{"key":"2025030617525889800_r31","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.4049\/jimmunol.157.11.5042","article-title":"Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS","volume":"157","author":"Yee","year":"1996","journal-title":"J. Immunol."},{"key":"2025030617525889800_r32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.193.8.981","article-title":"Protection from respiratory virus infections can be mediated by antigen-specific CD4+ T cells that persist in the lungs","volume":"193","author":"Hogan","year":"2001","journal-title":"J. Exp. Med."},{"key":"2025030617525889800_r33","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4049\/jimmunol.166.3.1813","article-title":"Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections","volume":"166","author":"Hogan","year":"2001","journal-title":"J. Immunol."},{"key":"2025030617525889800_r34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1074-7613(00)80102-8","article-title":"Interleukin-2 expression by a subpopulation of primary T cells is linked to enhanced memory\/effector function","volume":"11","author":"Saparov","year":"1999","journal-title":"Immunity"},{"key":"2025030617525889800_r35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"2025030617525889800_r36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4049\/jimmunol.1402975","article-title":"Airway-resident memory CD8 T cells provide antigen-specific protection against respiratory virus challenge through rapid IFN-\u03b3 production","volume":"195","author":"McMaster","year":"2015","journal-title":"J. Immunol."},{"key":"2025030617525889800_r37","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.4049\/jimmunol.169.12.6655","article-title":"Cutting edge: virus-specific CD4+ memory T cells in nonlymphoid tissues express a highly activated phenotype","volume":"169","author":"Cauley","year":"2002","journal-title":"J. Immunol."},{"key":"2025030617525889800_r38","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1002\/eji.1830251230","article-title":"Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system","volume":"25","author":"Oxenius","year":"1995","journal-title":"Eur. J. Immunol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/197\/7\/2738\/61581509\/1600879.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/197\/7\/2738\/61581509\/1600879.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T19:08:33Z","timestamp":1741288113000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/197\/7\/2738\/7974702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,1]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,10,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1600879","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,10]]},"published":{"date-parts":[[2016,10,1]]}}}